tldrdailynews.com logo

FDA Approves Groundbreaking Hair Loss Drug for Adolescents and Adults

1 min read
Source: Technology Networks
FDA Approves Groundbreaking Hair Loss Drug for Adolescents and Adults
Photo: Technology Networks
TL;DR

The FDA has approved LITFULO, a hair loss drug, to treat alopecia areata, an autoimmune disease that causes hair loss on the scalp, face, and body. The drug is approved for adults and adolescents aged 12 and over with severe alopecia areata. The drug inhibits two types of enzymes, blocking inflammatory signaling and cell-killing activity from T cells, which have been implicated in the development of alopecia areata. The clinical trial showed a statistically significant increase in hair coverage for those taking 50 mg of LITFULO compared to placebo.

Topics:businesshealth#alopecia-areata#fda#hair-loss#health#litfulo#pfizer
Share this article
  1. New Hair Loss Drug Approved by FDA  Technology Networks
  2. Pfizer's Litfulo boasts an alopecia edge over Lilly's Olumiant  FiercePharma
  3. Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata  PMLiVE
  4. FDA Approves Ritlecitinib for Alopecia Areata for Adolescents, Adults  Drug Topics
  5. FDA Approves First Drug for Adolescent Hair Loss  Newsmax

Want the full story? Read the original reporting

Read on Technology Networks